Книги з теми "Clozapine"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 книг для дослідження на тему "Clozapine".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте книги для різних дисциплін та оформлюйте правильно вашу бібліографію.
Bleakley, Stephen. Clozapine handbook. Dorsington: Lloyd-Reinhold Communications, 2013.
1941-, Jones Barry, Lapierre Yvon D, Canadian Psychiatric Association Meeting, Royal Society of Medicine Services (Great Britain), and Sandoz Canada, eds. Clozapine in treatment-resistant schizophrenia: A scientific update. London: Royal Society of Medicine Services, 1992.
Y, Meltzer Herbert, ed. Clozapine: A 5-year perspective and clinical recommendations. Memphis, TN: Physicians Postgraduate Press, 1996.
Glennie, Judith. Pharmacoeconomic evaluations of clozapine in treatment-resistant schizophrenia and risperidone in chronic schizophrenia. Ottawa, Ont: Canadian Coordinating Office for Health Technology Assessment, 1997.
Masellis, Mario. Pharmacogenetic analysis of serotonin receptors and clinical response to clozapine in schizophrenia patients. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.
Degen, Kathleen. Return from madness: Psychotherapy with people taking the new anti-psychotic medications and emerging from severe, lifelong, and disabling schizophrenia. Northvale, N.J: Aronson, 1996.
Naber, D., F. Müller-Spahn, and F. G. Pajonk, eds. Clozapin. Berlin, Heidelberg: Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-60551-2.
Meltzer, Herbert Y., and Hélio Elkis. Therapy-resistant schizophrenia. Basel: Karger, 2010.
United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopolies, and Business Rights. Marketing of Clozaril: Improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991. Washington: U.S. G.P.O., 1991.
Naber, Dieter, and Franz Müller-Spahn, eds. Clozapin Pharmakologie und Klinik eines atypischen Neuroleptikums. Berlin, Heidelberg: Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-93547-3.
Naber, Dieter, and Franz Müller-Spahn, eds. Clozapin Pharmakologie und Klinik eines atypischen Neuroleptikums. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-93565-7.
Sirfy, Ahmad. Dopamimetische Psychose bei Patienten mit idiopathischem Parkinson-Syndrom und verwandten Erkrankungen - eine retrospektive Analyse der Clozapin-Plasmaspiegel, der Dosis-Spiegel-Relation und Einflussfaktoren auf die Clozapin-Plasmaspiegel bei bestehender Clozapin-Medikation. [S.l: s.n.], 2013.
Meyer, Jonathan M., and Stephen M. Stahl. Clozapine Handbook: Stahl's Handbooks. Cambridge University Press, 2019.
Clozapine: The atypical antipsychotic. London: Royal College of Psychiatrists, 1992.
Meyer, Jonathan M., and Stephen M. Stahl. Clozapine Handbook: Stahl's Handbooks. University of Cambridge ESOL Examinations, 2021.
Lane, Chadrick, and Vinod H. Srihari. Clozapine for Treatment-Resistant Schizophrenia. Edited by Ish P. Bhalla, Rajesh R. Tampi, Vinod H. Srihari, and Michael E. Hochman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190625085.003.0040.
Barron, Daniel, and Noah Capurso. Clozapine for Suicidality in Schizophrenia. Edited by Ish P. Bhalla, Rajesh R. Tampi, Vinod H. Srihari, and Michael E. Hochman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190625085.003.0046.
Rohde, Christopher, and Jimmi Nielsen. Managing common adverse effects of clozapine. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0007.
Yuen, Eunice, and Cenk Tek. Effectiveness of Clozapine versus Other Atypical Antipsychotics. Edited by Ish P. Bhalla, Rajesh R. Tampi, Vinod H. Srihari, and Michael E. Hochman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190625085.003.0041.
Lerner, Vladimir. Clozapine: Medical Uses, Interactions and Side Effects. Nova Science Publishers, Incorporated, 2020.
Chanoch, Miodownik, Amir Krivoy, and Vladimir Lerner. Clozapine: Medical Uses, Interactions and Side Effects. Nova Science Publishers, Incorporated, 2020.
Leponex: Informationen für Betroffene, ihre Angehörigen und Freunde. Kössen, Germany: Pm-Verlag, 2007.
Brown, Julia. Clozapine Clinic: Health Agency in High-Risk Conditions. Taylor & Francis Group, 2022.
Brown, Julia E. H. Clozapine Clinic: Health Agency in High-Risk Conditions. Routledge, 2022.
Brown, Julia. Clozapine Clinic: Health Agency in High-Risk Conditions. Taylor & Francis Group, 2022.
Brown, Julia. Clozapine Clinic: Health Agency in High-Risk Conditions. Taylor & Francis Group, 2022.
Yang, Yvonne, and Stephen Marder. Pharmacological management of treatment-resistant schizophrenia: fundamentals of clozapine. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0006.
Barnes, Thomas R. E. Pharmacological management of treatment-resistant schizophrenia: alternatives to clozapine. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0009.
Clozapine congeners: Structural requirements for dopamine D4 receptor selectivity. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1995.
Gee, Siobhan, and David Taylor. Pharmacological management of treatment-resistant schizophrenia: advanced use of clozapine. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0008.
Lapierre, Y. Clozapine in Treatment-resistant Schizophrenia: A Scientifid Update (International Congress & Symposium). Royal Society of Medicine Press Ltd, 1992.
Publications, ICON Health. Clozapine - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.
Bond, Stephen. Impact of the pharmacist on resource utilization in an outpatient adult clozapine clinic. 1996.
Rowling, Corene. CLOZAPINE: A Prescription Drug Used to Treat a Schizoaffective Disorders or Psychotic Mood Issue. Independently Published, 2019.
Remington, Gary, Ofer Agid, Hiroyoshi Takeuchi, Jimmy Lee, and Araba Chintoh. Ultra-treatment resistance. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0012.
Hwang, Rudi. Pharmacogenetic analysis of dopamine receptor gene polymorphisms and clinical response to clozapine in patients with schizophrenia. 2006.
Howes, Oliver, ed. Treatment Response and Resistance in Schizophrenia. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.001.0001.
Abbas, Atheir I., and Jeffrey A. Lieberman. Pharmacological Treatments for Schizophrenia. Oxford University Press, 2015. http://dx.doi.org/10.1093/med:psych/9780199342211.003.0006.
Smith, Robert C., Stefan Leucht, and John M. Davis. Maximizing response to first-line antipsychotics in schizophrenia. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0003.
Burns, Tom, and Mike Firn. The role of medication. Edited by Tom Burns and Mike Firn. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198754237.003.0007.
Burns, Tom, and Mike Firn. Schizophrenia and delusional disorders. Edited by Tom Burns and Mike Firn. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198754237.003.0015.
Schulz, S. Charles, and Robert O. Friedel. Established and Novel Pharmacological Approaches to the Treatment of Personality Disorders. Edited by Christian Schmahl, K. Luan Phan, Robert O. Friedel, and Larry J. Siever. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199362318.003.0016.
Ellison, Justin C., Jason B. Rosenstock, and Michael J. Marcsisin. Somatic Treatments for Psychotic Disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199331505.003.0006.
Rose, Raquel, and Nicolette Molina. Interventions. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190260859.003.0010.
Douglas, Kevin S., Tonia L. Nicholls, and Johann Brink. Interventions for the Reduction of Violence by Persons with Serious Mental Illnesses. Edited by Phillip M. Kleespies. Oxford University Press, 2016. http://dx.doi.org/10.1093/oxfordhb/9780199352722.013.34.
Tracy, Derek K., and Fiona Gaughran. Treatment with medication: Side effects, adherence, and risk. Edited by Alec Buchanan and Lisa Wootton. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198738664.003.0009.
(Editor), Bart A. Ellenbroek, and Alexander R. Cools (Editor), eds. Atypical Antipsychotics (Milestones in Drug Therapy). Birkhäuser Basel, 2000.
Naber, Dieter, Franz Müller-Spahn, and F. G. Pajonk. Clozapin: Pharmakologie und Klinik Eines Atypischen Neuroleptikums. Springer London, Limited, 2013.
Naber, Dieter, Franz Müller-Spahn, and F. G. Pajonk. Clozapin: Pharmakologie und Klinik Eines Atypischen Neuroleptikums. Springer, 1997.
(Editor), Dieter Naber, and Franz Müller-Spahn (Editor), eds. Clozapin. Pharmakologie und Klinik eines atypischen Neuroleptikums: Neuere Aspekte der klinischen Praxis. Springer, 1996.